tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market
VRDN
Viridian Therapeutics
RESEARCH TOOLSreports

Viridian Therapeutics (VRDN) Stock News & Sentiment

Compare
1,459 Followers
Viridian Therapeutics: Advancing TED Pipeline, 2026 Catalysts, and New TSH Receptor Inhibitor Underpin Buy Rating
Premium
Ratings
Viridian Therapeutics: Advancing TED Pipeline, 2026 Catalysts, and New TSH Receptor Inhibitor Underpin Buy Rating
25d ago
VRDN
Viridian Therapeutics: 2026 Clinical and Regulatory Catalysts, Strong Balance Sheet Support Buy Rating on VRDN
Premium
Ratings
Viridian Therapeutics: 2026 Clinical and Regulatory Catalysts, Strong Balance Sheet Support Buy Rating on VRDN
25d ago
VRDN
Viridian Therapeutics: Building a Best-in-Class Thyroid Disease Franchise with Multiple Clinical Catalysts Supporting a Buy Rating
Premium
Ratings
Viridian Therapeutics: Building a Best-in-Class Thyroid Disease Franchise with Multiple Clinical Catalysts Supporting a Buy Rating
25d ago
VRDN
Viridian Therapeutics: Multiple 2026 Catalysts and Pipeline Momentum Underpin Buy Rating
Premium
Ratings
Viridian Therapeutics: Multiple 2026 Catalysts and Pipeline Momentum Underpin Buy Rating
25d ago
VRDN
Viridian Therapeutics: De-Risked Veligrotug Program and Compelling Phase III Data Support Undervalued Buy Rating
Premium
Ratings
Viridian Therapeutics: De-Risked Veligrotug Program and Compelling Phase III Data Support Undervalued Buy Rating
1M ago
VRDN
Viridian: Priority Review for Veligrotug and Catalyst-Rich 2026 Outlook Drive Price Target Raise and Buy Rating
Premium
Ratings
Viridian: Priority Review for Veligrotug and Catalyst-Rich 2026 Outlook Drive Price Target Raise and Buy Rating
1M ago
VRDN
3 Stocks Flashing Strong Buy Signals, Backed by Technical Analysis
Premium
Market News
3 Stocks Flashing Strong Buy Signals, Backed by Technical Analysis
1M ago
NGD
WVE
More VRDN News >

VRDN News on the Web

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA) and Viridian Therapeutics (VRDN)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Viridian Therapeutics (VRDN)
TipRanks News
Bullish
Why Viridian Therapeutics, Inc.’s (VRDN) Stock Is Up 5.75%
AAII
Neutral
Viridian Grants 16,650 Inducement Options as Pipeline Progresses in Thyroid Eye Disease
Market Chameleon
Neutral
Viridian Therapeutics initiated with a Buy at UBS
TipRanks News
Bullish
Viridian Therapeutics: Advancing TED Pipeline, 2026 Catalysts, and New TSH Receptor Inhibitor Underpin Buy Rating
TipRanks News
Bullish
Viridian Therapeutics: 2026 Clinical and Regulatory Catalysts, Strong Balance Sheet Support Buy Rating on VRDN
TipRanks News
Bullish
Viridian Therapeutics: Building a Best-in-Class Thyroid Disease Franchise with Multiple Clinical Catalysts Supporting a Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Positive
VRDN
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRDN’s Media Buzz Sentiment?
2 articles about VRDN were published this week. In an average week, 2.25 articles are published.
    What is VRDN’s weekly average amount of articles?
    In an average week, 2.25 articles about VRDN are published.
      What is VRDN’s News Sentiment?
      100% of articles about VRDN were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        IMAImageneBio
        HOCPFHOYA
        CBLControl Bionics Ltd.
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week